Oral tofacitinib, baricitinib and upadacitinib monotherapy for steroid-resistant vitiligo: A prospective case series

J Eur Acad Dermatol Venereol. 2025 Feb;39(2):e128-e130. doi: 10.1111/jdv.20109. Epub 2024 Jun 10.

Authors

Affiliation

¹ Department of Dermatology, Huashan Hospital Affiliated to Fudan University, Shanghai, China.

PMID: 38853646
DOI: 10.1111/jdv.20109

No abstract available

Publication types

Letter

Grants and funding